The Gene Rs1042522 C>G Polymorphism and Neuroblastoma Risk in Chinese Children

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2017 Mar 10

PMID 28275206

Citations 43

Authors

Jing He

Fenghua Wang

Jinhong Zhu

Zhuorong Zhang

Yan Zou

Ruizhong Zhang

Tianyou Yang

Huimin Xia

Affiliations

Soon will be listed here.

Abstract

, a tumor suppressor gene, plays a critical role in cell cycle control, apoptosis, and DNA damage repair. Previous studies have indicated that the gene Arg72Pro (rs1042522 C>G) polymorphism is associated with susceptibility to various types of cancer. We evaluated the association of the gene rs1042522 C>G polymorphism with neuroblastoma susceptibility in a hospital-based study among the Chinese Han population. Enrolled were 256 patients and 531 controls. Odds ratios (ORs) and 95% confidence intervals (CIs) generated using logistic regression models were used to determine the strength of the association of interest. No association was detected between rs1042522 C>G polymorphism and neuroblastoma risk. In our stratification analysis of age, gender, sites of origin, and clinical stages, we observed that subjects with rs1042522 CG/GG genotypes had a lower risk of developing neuroblastoma in the mediastinum (Adjusted OR=0.52, 95% CI=0.33-0.82, =0.005) than those carrying the CC genotype. These results indicate that gene rs1042522 C>G polymorphism may exert a weak and site-specific effect on neuroblastoma risk in Southern Chinese children and warrant further confirmation.

Citing Articles

The rs7404339 AA Genotype in Contributes to Increased Risks of Kawasaki Disease and Coronary Artery Lesions in a Southern Chinese Child Population.

Wang Y, Lin K, Zhang L, Lin Y, Yu H, Xu Y Front Cardiovasc Med. 2022; 9:760982.

PMID: 35571208 PMC: 9095914. DOI: 10.3389/fcvm.2022.760982.

Association of CMYC polymorphisms with hepatoblastoma risk.

Yang T, Wen Y, Li J, Tan T, Yang J, Pan J Transl Cancer Res. 2022; 9(2):849-855.

PMID: 35117430 PMC: 8798278. DOI: 10.21037/tcr.2019.12.19.

Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma.

Wong R, Wong M, Kuick C, Saffari S, Wong M, Tan S Front Oncol. 2021; 11:709525.

PMID: 34722256 PMC: 8551924. DOI: 10.3389/fonc.2021.709525.

Association between NER pathway gene polymorphisms and neuroblastoma risk in an eastern Chinese population.

Zhou C, Wang Y, He L, Zhu J, Li J, Tang Y Mol Ther Oncolytics. 2021; 20:3-11.

PMID: 33575466 PMC: 7851491. DOI: 10.1016/j.omto.2020.12.004.

rs11752942 A>G polymorphism decreases neuroblastoma risk in Chinese children.

Pan J, Lin H, Yang T, Yang J, Hu C, Zhu J Cell Cycle. 2020; 19(18):2367-2372.

PMID: 32809919 PMC: 7513837. DOI: 10.1080/15384101.2020.1808382.

References

Maris J . Recent advances in neuroblastoma. N Engl J Med. 2010; 362(23):2202-11. PMC: 3306838. DOI: 10.1056/NEJMra0804577. View

He J, Qiu L, Wang M, Hua R, Zhang R, Yu H . Polymorphisms in the XPG gene and risk of gastric cancer in Chinese populations. Hum Genet. 2012; 131(7):1235-44. DOI: 10.1007/s00439-012-1152-8. View

Han W, Zhou Y, Zhong R, Wu C, Song R, Zou L . Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population. PLoS One. 2013; 8(8):e71656. PMC: 3741122. DOI: 10.1371/journal.pone.0071656. View

Dahabreh I, Linardou H, Bouzika P, Varvarigou V, Murray S . TP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010; 19(7):1840-7. DOI: 10.1158/1055-9965.EPI-10-0156. View

He J, Zhang R, Zou Y, Zhu J, Yang T, Wang F . Evaluation of GWAS-identified SNPs at 6p22 with neuroblastoma susceptibility in a Chinese population. Tumour Biol. 2015; 37(2):1635-9. DOI: 10.1007/s13277-015-3936-7. View

Whibley C, Pharoah P, Hollstein M . p53 polymorphisms: cancer implications. Nat Rev Cancer. 2009; 9(2):95-107. DOI: 10.1038/nrc2584. View

Brodeur G, Pritchard J, Berthold F, Carlsen N, Castel V, Castelberry R . Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993; 11(8):1466-77. DOI: 10.1200/JCO.1993.11.8.1466. View

Tan H, Bao J, Zhou X . Genome-wide mutational spectra analysis reveals significant cancer-specific heterogeneity. Sci Rep. 2015; 5:12566. PMC: 4515826. DOI: 10.1038/srep12566. View

Smith M, Seibel N, Altekruse S, Ries L, Melbert D, OLeary M . Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010; 28(15):2625-34. PMC: 2881732. DOI: 10.1200/JCO.2009.27.0421. View

10.

Diskin S, Capasso M, Diamond M, Oldridge D, Conkrite K, Bosse K . Rare variants in TP53 and susceptibility to neuroblastoma. J Natl Cancer Inst. 2014; 106(4):dju047. PMC: 3982892. DOI: 10.1093/jnci/dju047. View

11.

Xu H . P53-responsive genes and the potential for cancer diagnostics and therapeutics development. Biotechnol Annu Rev. 2001; 7:131-64. DOI: 10.1016/s1387-2656(01)07035-1. View

12.

Moreno F, Lopez Marti J, Palladino M, Lobos P, Gualtieri A, Cacciavillano W . Childhood Neuroblastoma: Incidence and Survival in Argentina. Report from the National Pediatric Cancer Registry, ROHA Network 2000-2012. Pediatr Blood Cancer. 2016; 63(8):1362-7. DOI: 10.1002/pbc.25987. View

13.

Vousden K, Prives C . Blinded by the Light: The Growing Complexity of p53. Cell. 2009; 137(3):413-31. DOI: 10.1016/j.cell.2009.04.037. View

14.

Pim D, Banks L . p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer. 2003; 108(2):196-9. DOI: 10.1002/ijc.11548. View

15.

Dumont P, Leu J, Della Pietra 3rd A, George D, Murphy M . The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003; 33(3):357-65. DOI: 10.1038/ng1093. View

16.

DE Roos A, Teschke K, Savitz D, Poole C, Grufferman S, Pollock B . Parental occupational exposures to electromagnetic fields and radiation and the incidence of neuroblastoma in offspring. Epidemiology. 2001; 12(5):508-17. DOI: 10.1097/00001648-200109000-00008. View

17.

Matlashewski G, Tuck S, Pim D, Lamb P, Schneider J, CRAWFORD L . Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol. 1987; 7(2):961-3. PMC: 365159. DOI: 10.1128/mcb.7.2.961-963.1987. View

18.

Levine A . p53, the cellular gatekeeper for growth and division. Cell. 1997; 88(3):323-31. DOI: 10.1016/s0092-8674(00)81871-1. View

19.

Capasso M, Diskin S . Genetics and genomics of neuroblastoma. Cancer Treat Res. 2010; 155:65-84. DOI: 10.1007/978-1-4419-6033-7_4. View

20.

Zheng J, Zhang R, Zhu J, Wang F, Yang T, He J . Lack of Associations between Gene Polymorphisms and Neuroblastoma Susceptibility in a Chinese Population. Biomed Res Int. 2016; 2016:2932049. PMC: 5101359. DOI: 10.1155/2016/2932049. View